Chung-Wook Chung, Young-IL Jeong, Cy-Hyun Kim, Do-Hyung Kim, Hye-Myung Lee, Tae-Won Kwak, Dae-Hwan Kang
언어
영어(ENG)
URL
https://www.earticle.net/Article/A192907
※ 원문제공기관과의 협약기간이 종료되어 열람이 제한될 수 있습니다.
원문정보
초록
영어
Photodynamic therapy (PDT) is a palliative therapy for treatment of unresectable tumor and has been used to cure various kind of tumors. Recently, 5-aminolevulinic acid (ALA) has been used as a pro- photosensitizer, which can be transferred to intercellular protoporphyrin IX (PpIX), which is a strong photosensitizer, via the heme pathway. The main limitation of using ALA in PDT is the hydrophilic properties of ALA, which results in low cellular uptake. Chitosan is known to enhance mucosal delivery drugs and to enhance uptake of anticancer agent into tumor cells In this study, poly(ethylene glycol)-conjugated chitosan was synthesized and ALA-incorporated nanoparticle (CNP-ALA) was prepared for delivery of photosensitizer into human cholangiocarcinoma cells. CT26 murine colon carcinoma cells were treated with 0.1mM CNP-ALA or ALA for 24h. The effect of CNP-ALA was evaluated by monitoring the intra-converted PpIX amount and cell survival after irradiation under different light intensity. Results indicated that CNP-ALA as a nano-photosensitizer enhances intracellular PpIX generation and then cellular phototoxicity. We suggest that CNP-ALA is a promising carriers for photosensitizer to tumor cells.
본 학회는 화학, 생화학, 분자생물학, 미생물학, 식품공학, 의학, 약학, 유전공학 및 생물공학, 환경 및 기타 공업 등 전 분야의 탄수화물관련 이론과 기술을 연구 발전시키고 산학협동을 통해 이를 보급하여 국내 관련 산업의 발전 및 국민생활의 과학화에 기여하고자 하며, 이러한 목표와 비젼의 실현을 위해 회원들이 적극적인 참여와 활동을 전개하고자 한다.